LB-102 (50 mg tablet)
LB-102-008
Phase 3 small_molecule active
Quick answer
LB-102 (50 mg tablet) for Schizophrenia is a Phase 3 program (small_molecule) at LB PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LB PHARMACEUTICALS INC
- Indication
- Schizophrenia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active